Response to Letter to the Editor: "The impact of chemotherapy sequence on survival in node-positive invasive lobular carcinoma"

被引:0
|
作者
Fayanju, Oluwadamilola M. [1 ,2 ,3 ]
Williamson, Hannah V. [4 ]
机构
[1] Duke Univ, Med Ctr, Dept Surg, DUMC 3513, Durham, NC 27710 USA
[2] Duke Canc Inst, Womens Canc Program, Durham, NC USA
[3] Durham VA Med Ctr, Dept Surg, Durham, NC USA
[4] Duke Canc Inst, Biostat Shared Resource, Durham, NC USA
关键词
D O I
10.1002/jso.25594
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:566 / 566
页数:1
相关论文
共 50 条
  • [1] The impact of chemotherapy sequence on survival in node-positive invasive lobular carcinoma
    Tamirisa, Nina
    Williamson, Hannah V.
    Thomas, Samantha M.
    Westbrook, Kelly E.
    Greenup, Rachel A.
    Plichta, Jennifer K.
    Rosenberger, Laura H.
    Hyslop, Terry
    Hwang, Eun-Sil Shelley
    Fayanju, Oluwadamilola M.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (02) : 132 - 141
  • [2] The impact of chemotherapy sequence on survival in node-positive invasive lobular carcinoma
    Tamirisa, Nina Prabha
    Vernia, Hannah
    Thomas, Samantha M.
    Westbrook, Kelly E.
    Greenup, Rachel Adams
    Plichta, Jennifer Kay
    Rosenberger, Laura Horst
    Hyslop, Terry
    Hwang, Eun-Sil Shelley
    Fayanju, Oluwadamilola Motunrayo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] Neoadjuvant endocrine therapy vs chemotherapy in node-positive invasive lobular carcinoma
    Fayanju, Oluwadamilola
    Thornton, Madeline
    Williamson, Hannah
    Westbrook, Kelly
    Greenup, Rachel
    Plichta, Jennifer
    Rosenberger, Laura
    Gupta, Anjuli
    Hyslop, Terry
    Hwang, Eun-Sil
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : 41 - 42
  • [4] Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in Node-Positive Invasive Lobular Carcinoma
    Thornton, M. J.
    Williamson, H. V.
    Westbrook, K. E.
    Greenup, R. A.
    Plichta, J. K.
    Rosenberger, L. H.
    Gupta, A. M.
    Hyslop, T.
    Hwang, E. S.
    Fayanju, O. M.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (10) : 3166 - 3177
  • [5] Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in Node-Positive Invasive Lobular Carcinoma
    M. J. Thornton
    H. V. Williamson
    K. E. Westbrook
    R. A. Greenup
    J. K. Plichta
    L. H. Rosenberger
    A. M. Gupta
    T. Hyslop
    E. S. Hwang
    O. M. Fayanju
    [J]. Annals of Surgical Oncology, 2019, 26 : 3166 - 3177
  • [6] Adjuvant Chemotherapy for Node-positive Esophageal Squamous Cell Carcinoma Improves Survival
    Feng, Shao-Kang
    Liu, Xian-Ben
    Xing, Wen-Qun
    Liu, Yang
    Chen, Pei-Nan
    Jiang, Duo
    Sun, Hai-Bo
    [J]. ANNALS OF THORACIC SURGERY, 2022, 114 (04): : 1205 - 1213
  • [7] Survival outcomes after chemotherapy in invasive lobular carcinoma compared to estrogen receptor positive invasive ductal carcinoma
    Timbres, Jasmine
    Moss, Charlotte
    Mera, Anca
    Haire, Anna
    Gillett, Cheryl
    Van Hemelrijck, Mieke
    Sawyer, Elinor
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [8] Invasive lobular carcinoma classic type: Response to primary chemotherapy and survival outcomes
    Cristofanilli, M
    Gonzalez-Angulo, A
    Sneige, N
    Kau, SW
    Broglio, K
    Theriault, RL
    Valero, V
    Buzdar, AU
    Kuerer, H
    Buccholz, TA
    Hortobagyi, GN
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (01) : 41 - 48
  • [9] Neoadjuvant chemotherapy in invasive lobular breast carcinoma: Comparison of response, surgery and disease free survival with invasive ductal carcinoma
    Martin, Hilary L.
    Walsh, Geraldine
    Khabra, Komel
    Skinner, Tabitha
    Smith, Ian E.
    [J]. CANCER RESEARCH, 2015, 75
  • [10] Chemotherapy for older women with node-positive breast cancer - Response
    Levine, M
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2001, 165 (05) : 527 - 527